Renata (DHA:RENATA) 3-Year EBITDA Growth Rate : -14.10% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Renata 3-Year EBITDA Growth Rate?

Renata's EBITDA per Share for the three months ended in Dec. 2023 was BDT15.09.

During the past 12 months, Renata's average EBITDA Per Share Growth Rate was -39.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -14.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Renata was 27.80% per year. The lowest was -14.10% per year. And the median was 19.00% per year.

Competitive Comparison of Renata's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renata's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Renata's 3-Year EBITDA Growth Rate falls into.

Renata 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Renata (DHA:RENATA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Renata 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Renata's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Renata (DHA:RENATA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216

Website

https://www.renata-ltd.com

Renata Ltd is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata (DHA:RENATA) Headlines

No Headlines